Zinzino group revenue increased with a total of 54 %, compared with the previous year.
The revenue in April for Zinzino’s sales markets increased by 58 % and amounted to SEK 249.5 (158.0) million. Faun Pharma’s external sales decreased and amounted to SEK 6.2 (8.2) million.
Overall, the Group increased revenues by 54 % to SEK 255.7 (166.2) million compared with the previous year.
Accumulated revenue for January–April 2025 increased by 58 % to SEK 979.4 (620.7) million.
Revenues were distributed as follows:
Regions (MSEK)
Apr 2025
Apr 2024
Change
YTD 2025
YTD 2024
Change
The Nordics
23.5
25.0
-6%
100.7
93.0
8%
Central Europe
65.6
45.5
44%
262.0
165.0
59%
East Europe
27.2
31.1
-13%
124.4
124.9
0%
South & West Europe
45.0
26.4
70%
169.9
97.1
75%
The Baltics
8.7
8.2
6%
37.4
32.0
17%
North America
51.5
15.3
237%
164.0
50.7
223%
Asia-Pacific
26.3
5.4
387%
92.1
17.8
417%
Africa
1.7
1.1
55%
6.7
4.4
52%
Zinzino
249.5
158.0
58%
957.2
584.9
64%
Faun Pharma
6.2
8.2
-24%
22.2
35.8
-38%
Zinzino Group
255.7
166.2
54%
979.4
620.7
58%
Countries in regions:
The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA, Mexico
Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
Africa: South Africa
To view the full press release, please visit zinzino.com
About Zinzino
Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven